HOME >> BIOLOGY >> NEWS
Other highlights in the Aug. 7 JNCI

Vitamins and Minerals Showed Little Benefit on Liver Cancer Death Rates

Taking vitamins and minerals did not reduce liver cancer death rates in a study conducted by the National Cancer Institute and the Chinese Academy of Medical Sciences.

Liver cancer is a common cancer with a high death rate. New prevention strategies are needed to reduce the number of deaths from the disease.

Chen-Xu Qu, M.D., and colleagues conducted a randomized clinical trial that examined whether four vitamin-mineral supplement combinations could effect the liver cancer death rate in a Chinese population that was deficient in many vitamins and minerals. Study participants took two or four of the following combinations: retinol and zinc; riboflavin and niacin; ascorbic acid and molybdenum; beta-carotene, alpha-tocopherol, and selenium; or placebo pills.

After 5.25 years, none of the vitamin-mineral combinations caused a statistically significant reduction in liver cancer deaths overall. However, some combinations reduced risk in subgroups defined by age, sex, and alcohol consumption. These subgroup analyses need to be interpreted with caution, the authors write.

Contact: National Cancer Institute press office, ncipressofficers@mail.nih.gov, (301) 496-6641


Prior Testicular Cancer Diagnosis Has Little Impact on Second Cancer Survival

Testicular cancer survivors diagnosed with a second cancer had mortality rates similar to men diagnosed with a first cancer, except among some diagnosed with testicular cancer between 1973 and 1979.

Most testicular cancer patients are cured, but survivors are at a higher risk for second cancers later in life. There is little data on mortality rates of testicular cancer survivors with a second cancer.

Catherine Schairer, Ph.D., of the National Cancer Institute in Bethesda, Md., and colleagues co
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
7-Aug-2007


Page: 1 2 3

Related biology news :

1. Other highlights in the July 24 JNCI
2. Other highlights from the July 10 JNCI
3. Other highlights in JNCI, June 26
4. Other highlights in JNCI, June 12
5. Other highlights from the June 6 JNCI
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a specialty ... to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. , ... provides services to more than one dozen hospitals and surgery centers in the ...
(Date:6/4/2019)... ... June 04, 2019 , ... Harper was three years old when ... severe elbow dysplasia, which caused painful osteoarthritis in the joints. She was referred ... were heartbroken. , The surgical specialist, Dr. Christopher Eich of Southern California Veterinary ...
(Date:6/3/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading ... free, so be sure to register today to save your place! Participate in the ... our upcoming webinars: , CLINICAL TRIALS , June 10 – A Novel Approach to ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, ... Beasts Meet Biotech. The film focuses on regenerative veterinary medicine as a means ... was recently included in the Brentwood and Pacific Palisades International Film Festival ...
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
(Date:6/11/2019)... JUPITER, Fla. (PRWEB) , ... June 10, 2019 ... ... breakthroughs in science and technology in an upcoming episode, scheduled to broadcast 4Q/2019. ... of the Eppendorf Group) and will educate viewers about how its technology facilitates ...
(Date:6/11/2019)... ... 2019 , ... Veterinary Regenerative Medicine company, VetStem Biopharma ... that their GMP facility for cell production is now approved by the California ... an important milestone for VetStem as it expands into contract cell manufacturing services. ...
Breaking Biology Technology:
Cached News: